ReviewEye and vision (London, England)2025
Vitamin abnormalities in neuropathic corneal pain.
Review in Eye and vision (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Noncontact Esthesiometer: Large Cohort Study on Agreement with Contact Method and Correlations with Corneal Nerves and Ocular Surface.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Neuropathic corneal pain (NCP) refers to spontaneous corneal pain in the absence of stimuli arising from corneal nerve dysfunction with no clinically observable ocular surface abnormalities. It is debilitating with difficult-to-manage symptoms-burning pain, photophobia, and irritation being profound. However, evidence-based clinical recommendations for the management of NCP remain scarce. Given the established role of vitamins in various neuropathies and associations between vitamin deficiencies and NCP in the literature, vitamin supplementation represents a potential therapeutic avenue that has yet to be adequately investigated in the context of NCP. This narrative review provides an overview of the therapeutic potential of vitamins B3, B12 and D as treatment in NCP, drawing evidence from both preclinical animal and clinical studies. It discusses the potential mechanisms of action rendered by various vitamins in alleviating NCP and includes the suppression of inflammation, neuroinflammation, mitochondrial dysfunction, oxidative stress, as well as the modulation of neurodegeneration and nociception dysregulation. Furthermore, we offer insight on future directions needed for vitamin supplementation to serve as mainstream treatment for NCP. Future research should also aim to establish optimal treatment protocols, including dosing regimens, treatment duration and administration methods for each vitamin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.